Funded Tech Companies

Adcendo

Adcendo is a leading biopharmaceutical company, based in Copenhagen. Financial backing came from OrbiMed, Gilde Healthcare Partners and Jeito Capital.

Company Overview

Contact Information

Company Background Information

Overview

Adcendo ApS is a Copenhagen-based biotech company dedicated to developing highly differentiated antibody-drug conjugates (ADCs) for the treatment of underserved cancers. Antibody-drug conjugates (ADCs) represent an emerging drug modality, directing anticancer therapeutics to malignant cells overexpressing particular surface target molecules. 10+ ADCs are now in routine clinical use for cancer patients, with many more novel ADC assets currently investigated in clinical studies in solid tumors and hematologic malignancies

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/14/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Michael Pehl

        

Chief Operating Officer

Christoffer Nielsen

        

Chief Scientific Officer

Dominik Mumberg

        

Chief Technical Officer

Pernille Hemmingsen

        

Company Investors

• OrbiMed
• Gilde Healthcare Partners
• Jeito Capital (Ksenija Pavletic)
• EIFO
• Bpifrance
• RA Capital Management
• Venrock
• Healthcap Venture Capital
• Logos Capital
• Vida Ventures (Rajul Jain)
• TCGX
• Pontifax Venture Capital
• TPG Growth
• Dawn Biopharma (Iyona Rajkomar)
• Novo Holdings
• Ysios Capital
• Surveyor Capital
• TPG Capital
• Venrock Healthcare Capital Partners

Browse more funded tech companies:

Adcade | Adcentrx Therapeutics

Share this article

About Our VC Deals Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary